Tissue Penetration and Metabolism of Ciprofloxacin

Overview

Journal Am J Med

Specialty General Medicine

Date 1987 Apr 27

PMID 3578319

Citations 14

Authors

R Wise

I A Donovan

Affiliations

Soon will be listed here.

Abstract

The tissue penetration of ciprofloxacin was studied by two methods. Penetration into inflammatory fluid following oral administration (500 mg) was 117 percent; following intravenous administration (100 mg), penetration was 121 percent. The penetration of ciprofloxacin into uninflamed peritoneum following intravenous administration (100 mg) was 95 percent.

Citing Articles

Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.

Aminimanizani A, Beringer P, Jelliffe R Clin Pharmacokinet. 2001; 40(3):169-87.

PMID: 11327197 DOI: 10.2165/00003088-200140030-00003.

Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients.

Muller M, Brunner M, Hollenstein U, Joukhadar C, Schmid R, Minar E Antimicrob Agents Chemother. 1999; 43(8):2056-8.

PMID: 10428936 PMC: 89414. DOI: 10.1128/AAC.43.8.2056.

Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Monk J, Price A, Benfield P, Todd P, Ward A Drugs. 1988; 35(4):373-447.

PMID: 3292209 DOI: 10.2165/00003495-198835040-00003.

Unusual presentation of pseudomonas infection.

Weinbren M, Forgeson G, Helenglass G, Jameson B, Powles R BMJ. 1988; 297(6655):1034-5.

PMID: 3142602 PMC: 1834763. DOI: 10.1136/bmj.297.6655.1034.

Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Paton J, Reeves D Drugs. 1988; 36(2):193-228.

PMID: 3053126 DOI: 10.2165/00003495-198836020-00004.